BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 27025239)

  • 1. Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.
    Massengill MT; Ashraf HM; Chowdhury RR; Chrzanowski SM; Kar J; Warren SA; Walter GA; Zeng H; Kang BH; Anderson RH; Moss RL; Kasahara H
    Cardiovasc Res; 2016 Jul; 111(1):34-43. PubMed ID: 27025239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myosin light chain phosphorylation is critical for adaptation to cardiac stress.
    Warren SA; Briggs LE; Zeng H; Chuang J; Chang EI; Terada R; Li M; Swanson MS; Lecker SH; Willis MS; Spinale FG; Maupin-Furlowe J; McMullen JR; Moss RL; Kasahara H
    Circulation; 2012 Nov; 126(22):2575-88. PubMed ID: 23095280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of Cardiac Myosin Light Chain Kinase Ameliorates Systolic Dysfunction by Reducing Superrelaxed Myosin.
    Hitsumoto T; Tsukamoto O; Matsuoka K; Li J; Liu L; Kuramoto Y; Higo S; Ogawa S; Fujino N; Yoshida S; Kioka H; Kato H; Hakui H; Saito Y; Okamoto C; Inoue H; Hyejin J; Ueda K; Segawa T; Nishimura S; Asano Y; Asanuma H; Tani A; Imamura R; Komagawa S; Kanai T; Takamura M; Sakata Y; Kitakaze M; Haruta JI; Takashima S
    Circulation; 2023 Jun; 147(25):1902-1918. PubMed ID: 37128901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart Failure Induced by Perinatal Ablation of Cardiac Myosin Light Chain Kinase.
    Islam YF; Joseph R; Chowdhury RR; Anderson RH; Kasahara H
    Front Physiol; 2016; 7():480. PubMed ID: 27833563
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac myosin light chain kinase is necessary for myosin regulatory light chain phosphorylation and cardiac performance in vivo.
    Ding P; Huang J; Battiprolu PK; Hill JA; Kamm KE; Stull JT
    J Biol Chem; 2010 Dec; 285(52):40819-29. PubMed ID: 20943660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac functional improvement in rats with myocardial infarction by up-regulating cardiac myosin light chain kinase with neuregulin.
    Gu X; Liu X; Xu D; Li X; Yan M; Qi Y; Yan W; Wang W; Pan J; Xu Y; Xi B; Cheng L; Jia J; Wang K; Ge J; Zhou M
    Cardiovasc Res; 2010 Nov; 88(2):334-43. PubMed ID: 20615916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of heart-specific small subunit of myosin light chain phosphatase results in heart failure and conduction disturbance.
    Arimura T; Muchir A; Kuwahara M; Morimoto S; Ishikawa T; Du CK; Zhan DY; Nakao S; Machida N; Tanaka R; Yamane Y; Hayashi T; Kimura A
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1192-H1202. PubMed ID: 29451818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-4 deficiency accelerates the transition from compensated hypertrophy to heart failure following pressure overload.
    Li G; Xie J; Chen J; Li R; Wu H; Zhang X; Chen Q; Gu R; Xu B
    Cardiovasc Pathol; 2017; 28():74-79. PubMed ID: 28395201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly.
    Ai J; Zhang R; Gao X; Niu HF; Wang N; Xu Y; Li Y; Ma N; Sun LH; Pan ZW; Li WM; Yang BF
    Cardiovasc Res; 2012 Aug; 95(3):385-93. PubMed ID: 22719074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cardiac myosin light chain kinase gene mutation on development of dilated cardiomyopathy.
    Hodatsu A; Fujino N; Uyama Y; Tsukamoto O; Imai-Okazaki A; Yamazaki S; Seguchi O; Konno T; Hayashi K; Kawashiri MA; Asano Y; Kitakaze M; Takashima S; Yamagishi M
    ESC Heart Fail; 2019 Apr; 6(2):406-415. PubMed ID: 30690923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac myosin regulatory light chain kinase modulates cardiac contractility by phosphorylating both myosin regulatory light chain and troponin I.
    Sevrieva IR; Brandmeier B; Ponnam S; Gautel M; Irving M; Campbell KS; Sun YB; Kampourakis T
    J Biol Chem; 2020 Apr; 295(14):4398-4410. PubMed ID: 32086378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Isoform of Cardiac Myosin Light Chain Kinase and the Role of Cardiac Myosin Phosphorylation in α1-Adrenoceptor Mediated Inotropic Response.
    Taniguchi M; Okamoto R; Ito M; Goto I; Fujita S; Konishi K; Mizutani H; Dohi K; Hartshorne DJ; Itoh T
    PLoS One; 2015; 10(10):e0141130. PubMed ID: 26512720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload.
    Ahmad F; Singh AP; Tomar D; Rahmani M; Zhang Q; Woodgett JR; Tilley DG; Lal H; Force T
    J Mol Cell Cardiol; 2019 May; 130():65-75. PubMed ID: 30928428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of cardiac myosin light chain kinase by matrix metalloproteinase-2 contributes to myocardial contractile dysfunction during ischemia/reperfusion.
    Gao L; Zheng YJ; Gu SS; Tan JL; Paul C; Wang YG; Yang HT
    J Mol Cell Cardiol; 2014 Dec; 77():102-12. PubMed ID: 25451385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
    Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
    Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.
    Sung MM; Byrne NJ; Kim TT; Levasseur J; Masson G; Boisvenue JJ; Febbraio M; Dyck JR
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H552-H560. PubMed ID: 28062415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
    Streicher JM; Ren S; Herschman H; Wang Y
    Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous
    Tougas CL; Grindrod T; Cai LX; Alkassis FF; Kasahara H
    Front Physiol; 2019; 10():696. PubMed ID: 31244672
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of neuregulin on cardiac Myosin light chain kinase gene-ablated hearts.
    Chang AN; Huang J; Battiprolu PK; Hill JA; Kamm KE; Stull JT
    PLoS One; 2013; 8(6):e66720. PubMed ID: 23776695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.